A Functional Role of S100A4/Non-Muscle Myosin IIA Axis for Pro-Tumorigenic Vascular Functions in Glioblastoma
April 2022
in “
Cell Communication and Signaling
”
TLDR High S100A4 levels worsen glioblastoma by promoting blood vessel growth.
The study explored the S100A4/non-muscle myosin IIA (NMIIA) axis in glioblastoma (GBM) using 94 samples, revealing that S100A4 overexpression was linked to increased microvascular density and poor survival outcomes. S100A4(+)/HIF-1α(−) cells enhanced tumor progression by promoting vascular functions through NMIIA inhibition and VEGF release. Hypoxia-induced S100A4 expression was associated with increased cell mobility and vascularization, with high S100A4 levels correlating with worse prognosis. The study highlighted the potential of targeting the S100A4/NMIIA axis for therapeutic intervention in GBM.